Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men

Katia Margiotti, Eugene Kim, C. Leigh Pearce, Enrico Spera, Giuseppe Novelli, Juergen K V Reichardt

Research output: Contribution to journalArticle

Abstract

BACKGROUND. Prostate cancer is a significant public health problem in this country. Substantial data support a plausible role for androgens in the etiology of this disease. The human HSD17B3 gene encodes the testicular (or type III) 17β-hydroxysteroid dehydrogenase enzyme, which catalyzes testosterone biosynthesis in men. METHODS. We have investigated the G289S (glycine at codon 289 replaced by serine) polymorphism at the HSD17B3 locus as a candidate single nucleotide polymorphism (SNP) for prostate cancer risk in constitutional DNA from 103 Italian prostate cancer patients and 109 Italian disease-free centenarians to assess the role of this SNP in susceptibility to prostate cancer. RESULTS. The G289S polymorphism confers a significant increase in risk for prostate cancer (odds ratio=2.5; 95% confidence interval, 1.03-6.07) in our study population. CONCLUSION. Our data are consistent with a plausible role of the G289S SNP in prostate cancer susceptibility. Therefore, the HSD17B3 gene may be a plausible candidate gene for prostate cancer risk.

Original languageEnglish
Pages (from-to)65-68
Number of pages4
JournalProstate
Volume53
Issue number1
DOIs
Publication statusPublished - Sep 15 2002

Fingerprint

Single Nucleotide Polymorphism
Prostatic Neoplasms
Genes
Codon
Glycine
Serine
Androgens
Testosterone
Public Health
Odds Ratio
Confidence Intervals
DNA
Enzymes
Population

Keywords

  • 17β-hydroxysteroid dehydrogenase
  • Androgen metabolism
  • SNP

ASJC Scopus subject areas

  • Urology

Cite this

Margiotti, K., Kim, E., Pearce, C. L., Spera, E., Novelli, G., & Reichardt, J. K. V. (2002). Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men. Prostate, 53(1), 65-68. https://doi.org/10.1002/pros.10134

Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men. / Margiotti, Katia; Kim, Eugene; Pearce, C. Leigh; Spera, Enrico; Novelli, Giuseppe; Reichardt, Juergen K V.

In: Prostate, Vol. 53, No. 1, 15.09.2002, p. 65-68.

Research output: Contribution to journalArticle

Margiotti, K, Kim, E, Pearce, CL, Spera, E, Novelli, G & Reichardt, JKV 2002, 'Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men', Prostate, vol. 53, no. 1, pp. 65-68. https://doi.org/10.1002/pros.10134
Margiotti, Katia ; Kim, Eugene ; Pearce, C. Leigh ; Spera, Enrico ; Novelli, Giuseppe ; Reichardt, Juergen K V. / Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men. In: Prostate. 2002 ; Vol. 53, No. 1. pp. 65-68.
@article{3c8bbdea59cf4f289a57d2cb052d2df1,
title = "Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men",
abstract = "BACKGROUND. Prostate cancer is a significant public health problem in this country. Substantial data support a plausible role for androgens in the etiology of this disease. The human HSD17B3 gene encodes the testicular (or type III) 17β-hydroxysteroid dehydrogenase enzyme, which catalyzes testosterone biosynthesis in men. METHODS. We have investigated the G289S (glycine at codon 289 replaced by serine) polymorphism at the HSD17B3 locus as a candidate single nucleotide polymorphism (SNP) for prostate cancer risk in constitutional DNA from 103 Italian prostate cancer patients and 109 Italian disease-free centenarians to assess the role of this SNP in susceptibility to prostate cancer. RESULTS. The G289S polymorphism confers a significant increase in risk for prostate cancer (odds ratio=2.5; 95{\%} confidence interval, 1.03-6.07) in our study population. CONCLUSION. Our data are consistent with a plausible role of the G289S SNP in prostate cancer susceptibility. Therefore, the HSD17B3 gene may be a plausible candidate gene for prostate cancer risk.",
keywords = "17β-hydroxysteroid dehydrogenase, Androgen metabolism, SNP",
author = "Katia Margiotti and Eugene Kim and Pearce, {C. Leigh} and Enrico Spera and Giuseppe Novelli and Reichardt, {Juergen K V}",
year = "2002",
month = "9",
day = "15",
doi = "10.1002/pros.10134",
language = "English",
volume = "53",
pages = "65--68",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men

AU - Margiotti, Katia

AU - Kim, Eugene

AU - Pearce, C. Leigh

AU - Spera, Enrico

AU - Novelli, Giuseppe

AU - Reichardt, Juergen K V

PY - 2002/9/15

Y1 - 2002/9/15

N2 - BACKGROUND. Prostate cancer is a significant public health problem in this country. Substantial data support a plausible role for androgens in the etiology of this disease. The human HSD17B3 gene encodes the testicular (or type III) 17β-hydroxysteroid dehydrogenase enzyme, which catalyzes testosterone biosynthesis in men. METHODS. We have investigated the G289S (glycine at codon 289 replaced by serine) polymorphism at the HSD17B3 locus as a candidate single nucleotide polymorphism (SNP) for prostate cancer risk in constitutional DNA from 103 Italian prostate cancer patients and 109 Italian disease-free centenarians to assess the role of this SNP in susceptibility to prostate cancer. RESULTS. The G289S polymorphism confers a significant increase in risk for prostate cancer (odds ratio=2.5; 95% confidence interval, 1.03-6.07) in our study population. CONCLUSION. Our data are consistent with a plausible role of the G289S SNP in prostate cancer susceptibility. Therefore, the HSD17B3 gene may be a plausible candidate gene for prostate cancer risk.

AB - BACKGROUND. Prostate cancer is a significant public health problem in this country. Substantial data support a plausible role for androgens in the etiology of this disease. The human HSD17B3 gene encodes the testicular (or type III) 17β-hydroxysteroid dehydrogenase enzyme, which catalyzes testosterone biosynthesis in men. METHODS. We have investigated the G289S (glycine at codon 289 replaced by serine) polymorphism at the HSD17B3 locus as a candidate single nucleotide polymorphism (SNP) for prostate cancer risk in constitutional DNA from 103 Italian prostate cancer patients and 109 Italian disease-free centenarians to assess the role of this SNP in susceptibility to prostate cancer. RESULTS. The G289S polymorphism confers a significant increase in risk for prostate cancer (odds ratio=2.5; 95% confidence interval, 1.03-6.07) in our study population. CONCLUSION. Our data are consistent with a plausible role of the G289S SNP in prostate cancer susceptibility. Therefore, the HSD17B3 gene may be a plausible candidate gene for prostate cancer risk.

KW - 17β-hydroxysteroid dehydrogenase

KW - Androgen metabolism

KW - SNP

UR - http://www.scopus.com/inward/record.url?scp=0037106035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037106035&partnerID=8YFLogxK

U2 - 10.1002/pros.10134

DO - 10.1002/pros.10134

M3 - Article

C2 - 12210481

AN - SCOPUS:0037106035

VL - 53

SP - 65

EP - 68

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 1

ER -